Skip to main content
Equibles

BIT Capital GmbH

Position in VIR — Vir Biotechnology, Inc.

CIK 2053305 BERLIN, 2M
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$815,200
+$546,400 QoQ
Shares Held
80,000
+166.7% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#97
of 237 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Derivatives in VIR

reported options exposure · as of Dec 31, 2021
CallValue
$1,674,800
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BIT Capital GmbH holds $38,342,132 across 19 Biotechnology names. VIR ranks #16 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IDYA
IDEAYA Biosciences, Inc.
 311,333 $11,603,380
2 DFTX
Definium Therapeutics, Inc.
 128,131 $6,027,282
3 RARE
Ultragenyx Pharmaceutical Inc.
 91,391 $3,051,545
4 RCUS
Arcus Biosciences, Inc.
 60,000 $1,849,800
5 IMNM
Immunome Inc.
 83,400 $1,767,246
6 ATAI
AtaiBeckley Inc.
 320,576 $1,689,435
7 NKTR
Nektar Therapeutics
 21,100 $1,472,991
8 IONS
Ionis Pharmaceuticals Inc
 16,300 $1,292,427

All Filings in VIR

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $815,200 80,000
2026-03-31 $268,800 30,000
2023-03-31 $224,555 9,650
2021-12-31 $1,674,800 40,000
2021-12-31 $1,674,800 40,000